This programme is operated by UK NEQAS Immunocytochemistry & In-Situ Hybridisation for further information on the operation of the programme or details on current accreditation status please contact UK NEQAS Immunocytochemistry & In-Situ Hybridisation directly.
The External Quality Assessment Scheme for Immunocytochemistry was founded in 1985 by Mr Gerry Reynolds at Mount Vernon Hospital, Middlesex. In 1988 the Service was recognised by the UK Department of Health and from that time it became known as the UK National External Quality Assessment Service for Immunocytochemistry (UK NEQAS-ICC and later, when it incorporated in-situ hybridisation methods, as UKNEQAS ICC & ISH).